Table 2.
CAD patients | Controls | OR (95% CI) | P | Adjusted* OR (95% CI) | P | |
---|---|---|---|---|---|---|
GSTM1 | ||||||
Active | 12 (41.4) | 16 (53.3) | ||||
Null | 17 (58.6) | 14 (46.7) | 1.619 (0.578–4.534) | 0.510† | 0.325 (0.082–1.293) | 0.111 |
GSTT1 | ||||||
Active | 23 (79.3) | 25 (83.3) | ||||
Null | 6 (20.7) | 5 (16.7) | 1.304 (0.350–4.858) | 0.950† | 1.005 (0.200–5.041) | 0.995 |
hOGG1 | ||||||
Ser/Ser | 15 (51.7) | 17(56.7) | ||||
Ser/Cys | 12 (41.4) | 11 (36.7) | 1.236 (0.423–3.615) | 0.909† | 1.230 (0.327–4.631) | 0.759 |
Cys/Cys | 2 (6.9) | 2 (6.7) | 1.133 (0.142–9.065) | 1.000‡ | 0.510 (0.038–6.861) | 0.612 |
Adjusted for age, gender, presence of hypertension and smoking habits;
Continuity correction chi-square test;
Fisher’s exact test; CAD - coronary artery disease